Genital Wart Treatment: What the Options Can and Cannot Do

Treatment for genital warts is aimed at removing or reducing visible warts and relieving symptoms. It does not reliably eradicate HPV infection from the body, and no single treatment is appropriate for every lesion. Some confirmed warts can be observed because they may regress spontaneously; others are treated with prescription topical medicines or clinician-applied methods such as cryotherapy, chemical treatment, electrosurgery, excision or laser. The appropriate option depends on the diagnosis, site, number and size of lesions, patient factors and local expertise.

Can genital warts disappear without treatment?

Yes. In the absence of treatment, some anogenital warts regress, some persist and others become larger or more numerous. Observation can therefore be discussed for selected patients when the diagnosis is secure and there are no concerning features.

Observation should not be used as a substitute for diagnosis when a lesion is atypical, changing, ulcerated, bleeding or otherwise suspicious.

Does genital-wart treatment remove HPV from the body?

Not necessarily. This is one of the most important limits of treatment.

Current therapies target the wart, not a hidden reservoir of HPV throughout the skin and mucosa. After a wart has cleared:

• HPV may still be detectable or transmissible;
• another wart may appear;
• a person cannot be given a precise date on which HPV has been eliminated;
• treatment response does not prove that future transmission risk is zero.

For this reason, “wart clearance” and “viral clearance” should not be used as interchangeable terms.

Does every genital wart need treatment?

No. Treatment is considered according to symptoms, extent, site, patient preference, confidence in the diagnosis and the expected burden of treatment.

Reasons a person may choose active treatment include:

• irritation, itching, tenderness or bleeding from friction;
• increasing number or size of lesions;
• a location that causes functional or hygiene problems;
• psychosocial distress;
• preference to remove visible lesions after informed discussion.

Reasons to reassess before treatment include diagnostic uncertainty, atypical morphology, immunosuppression or concern that the lesion may not be a benign wart.

Why should the diagnosis be confirmed before treatment?

Because many genital lesions are not HPV warts. Pearly penile papules, molluscum, skin tags, folliculitis, seborrhoeic keratoses, condylomata lata and premalignant lesions can be mistaken for genital warts.

Applying a destructive treatment to the wrong diagnosis can cause injury and delay appropriate care. Routine HPV testing does not solve this problem because HPV testing is not recommended to diagnose anogenital warts.

Read how genital warts are assessed.

How is a treatment option selected?

Treatment selection can depend on:

• wart size and number;
• anatomical site;
• whether the lesions are external or internal;
• whether all lesions can be reached safely by the patient;
• previous treatments and response;
• immune status;
• pregnancy where relevant;
• potential adverse effects, healing time and scarring risk;
• patient preference;
• local availability and clinician experience.

Both CDC and BASHH guidance emphasise that there is no single ideal treatment for all patients and all warts.

Which prescription treatments can be applied by the patient?

Depending on country, lesion site and prescribing rules, patient-applied treatments may include agents such as:

• imiquimod, an immune-response modifier;
• podofilox/podophyllotoxin, an antimitotic treatment;
• sinecatechins, a topical botanical extract preparation available in some settings.

These medicines are not interchangeable. Each has specific instructions, contraindications, local-reaction profiles and anatomical restrictions. The patient should know exactly which lesions are being treated and how to protect surrounding skin.

This page intentionally does not provide a personalised dosing schedule. Product formulation and authorised use differ by country and patient circumstance.

Which treatments are applied by a clinician?

Clinician-applied options can include:

Cryotherapy

Liquid nitrogen or another appropriate cryotherapy system is used to freeze wart tissue. Local pain, blistering, pigment change and tissue irritation can occur, and more than one treatment session may be needed.

Surgical or ablative removal

Depending on lesion pattern and setting, removal may involve excision, curettage, electrosurgery or laser. These methods can remove a substantial amount of wart tissue during one procedure, which may be useful for larger or extensive disease, but recurrence can still occur.

Trichloroacetic or bichloroacetic acid

These clinician-applied caustic agents chemically destroy wart tissue. They require careful application because excess acid can damage adjacent skin.

The availability of individual methods differs between healthcare systems.

How are large or numerous genital warts managed?

Extensive disease may be less practical to treat with repeated self-applied therapy alone. Clinician-administered ablative or surgical options may therefore be considered, sometimes after discussing staged treatment.

The decision is not simply “bigger wart = surgery”. Location, healing risk, pain control, previous response and diagnostic confidence still matter.

What about warts at the urethral opening or inside the anal canal?

Internal or difficult-to-access lesions need site-specific assessment.

For urethral-meatal or suspected intraurethral lesions, urological evaluation may be appropriate. External perianal warts can coexist with intra-anal disease; symptoms or examination findings may lead to digital examination or anoscopy. Intra-anal warts may require colorectal or sexual-health expertise depending on the local system.

Self-applied medicines intended for external warts should not be used inside the urethra or anal canal unless a product is specifically authorised and prescribed for that site.

How is treatment different during pregnancy?

Pregnancy changes which treatments can be used. CDC guidance states that podofilox/podophyllin and sinecatechins should not be used during pregnancy, and imiquimod is generally avoided until more pregnancy data are available.

Treatment planning in pregnancy should therefore be made with the relevant obstetric/gynaecological clinician. This page is not a substitute for pregnancy-specific prescribing advice.

Does immunosuppression change genital-wart treatment?

People with HIV or other causes of immunosuppression may develop larger or more numerous warts, respond less predictably to therapy and experience more frequent recurrence. Atypical lesions may also warrant a lower threshold for biopsy.

This does not automatically mean that completely different wart treatments must be used. Current CDC guidance does not support a separate universal treatment algorithm solely because a person is immunocompromised, but closer assessment may be appropriate.

What should not be used as a home treatment?

Do not apply ordinary hand-and-foot wart acids, household chemicals, corrosive substances or unregulated “burning” products to genital tissue. Cutting, tying off, puncturing or scraping a genital lesion is also unsafe.

These approaches can cause:

• chemical burns;
• ulceration;
• bleeding;
• infection;
• scarring;
• loss of diagnostic information if the lesion was not actually a wart.

A treatment described as “natural” is not automatically safe for genital skin or mucosa.

How long does treatment take?

There is no single duration. It depends on the treatment method, number and location of lesions, local tissue response and whether a new modality is needed.

CDC notes that anogenital warts typically respond within about three months of therapy, while BASHH uses treatment-specific review points for some topical treatments. This does not mean every wart should be gone by a fixed deadline.

Lack of meaningful response after a complete treatment course, or severe adverse effects, is a reason to reassess the diagnosis and treatment plan rather than simply continuing indefinitely.

What should be considered during treatment?

Practical points can include:

• using only the prescribed product on the identified lesions;
• protecting surrounding healthy skin where relevant;
• following advice about washing, sexual contact and wound care for the specific treatment;
• allowing open or eroded treatment sites to heal;
• seeking review for severe pain, extensive ulceration, infection or significant bleeding;
• avoiding unplanned combinations of multiple destructive methods.

Some topical products can affect condom or diaphragm integrity, so product-specific information matters.

Can genital warts come back after treatment?

Yes. Recurrence is common enough that it should be discussed before treatment. CDC counselling guidance notes that recurrence is particularly common in the first three months after treatment.

A recurrence does not automatically mean that treatment was performed incorrectly, that the partner has newly reinfected the patient or that the relationship is not monogamous.

Read why genital warts can recur.

When is reassessment needed?

Reassessment is appropriate when:

• the lesion does not respond after an adequate treatment course;
• the disease worsens during treatment;
• significant adverse effects develop;
• a previously typical lesion becomes hard, fixed, ulcerated or repeatedly bleeds;
• a new lesion has a different appearance;
• urinary or anal symptoms suggest internal disease;
• the diagnosis was never secure.

The next step may be a different treatment, biopsy, a site-specific examination or recognition that the lesion was not a wart.

Common questions

Is cryotherapy preferable to a cream in every case?

No. The preferred option varies with the lesion and patient context. Choice depends on lesion characteristics, patient factors and treatment availability.

Can a laser prevent recurrence?

No treatment can promise that a wart will never recur. Laser is one clinician-applied option for selected lesions, not a method for guaranteeing viral eradication.

Should a wart be removed as soon as it appears?

Not necessarily. Observation may be reasonable for selected confirmed warts, while atypical or symptomatic lesions may need earlier assessment or treatment.

Can vaccination replace wart treatment?

No. HPV vaccination is preventive and does not treat an existing genital wart.

Should a partner receive the same treatment even without a wart?

No. There is no treatment for an asymptomatic partner simply to “clear HPV”. Partner examination or STI testing may be appropriate according to symptoms and risk.

Medical information note

Genital-wart treatment is selected after diagnosis and anatomical assessment. Prescription medicines and procedures have different contraindications and adverse-effect profiles; individual instructions should come from the treating clinician and the authorised product information in the relevant country.